Global Recombinant Hepatitis B Vaccine Sales Market Report 2024

Report ID: 884168 | Published Date: Jan 2025 | No. of Page: 144 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Recombinant Hepatitis B Vaccine Market Overview
    1.1 Recombinant Hepatitis B Vaccine Product Scope
    1.2 Recombinant Hepatitis B Vaccine Segment by Type
        1.2.1 Global Recombinant Hepatitis B Vaccine Sales by Type (2016 & 2021 & 2027)
        1.2.2 10mcg/ml
        1.2.3 10mcg/0.5ml
    1.3 Recombinant Hepatitis B Vaccine Segment by Application
        1.3.1 Global Recombinant Hepatitis B Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
        1.3.2 Newborn
        1.3.3 Primary School Students
        1.3.4 Adult
    1.4 Recombinant Hepatitis B Vaccine Market Estimates and Forecasts (2016-2027)
        1.4.1 Global Recombinant Hepatitis B Vaccine Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global Recombinant Hepatitis B Vaccine Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global Recombinant Hepatitis B Vaccine Price Trends (2016-2027)

2 Recombinant Hepatitis B Vaccine Estimates and Forecasts by Region
    2.1 Global Recombinant Hepatitis B Vaccine Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global Recombinant Hepatitis B Vaccine Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global Recombinant Hepatitis B Vaccine Sales Market Share by Region (2016-2021)
        2.2.2 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Region (2016-2021)
    2.3 Global Recombinant Hepatitis B Vaccine Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global Recombinant Hepatitis B Vaccine Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global Recombinant Hepatitis B Vaccine Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America Recombinant Hepatitis B Vaccine Estimates and Projections (2016-2027)
        2.4.2 Europe Recombinant Hepatitis B Vaccine Estimates and Projections (2016-2027)
        2.4.3 China Recombinant Hepatitis B Vaccine Estimates and Projections (2016-2027)
        2.4.4 Japan Recombinant Hepatitis B Vaccine Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia Recombinant Hepatitis B Vaccine Estimates and Projections (2016-2027)
        2.4.6 India Recombinant Hepatitis B Vaccine Estimates and Projections (2016-2027)
3 Global Recombinant Hepatitis B Vaccine Competition Landscape by Players
    3.1 Global Top Recombinant Hepatitis B Vaccine Players by Sales (2016-2021)
    3.2 Global Top Recombinant Hepatitis B Vaccine Players by Revenue (2016-2021)
    3.3 Global Recombinant Hepatitis B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Hepatitis B Vaccine as of 2020)
    3.4 Global Recombinant Hepatitis B Vaccine Average Price by Company (2016-2021)
    3.5 Manufacturers Recombinant Hepatitis B Vaccine Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Recombinant Hepatitis B Vaccine Market Size by Type
    4.1 Global Recombinant Hepatitis B Vaccine Historic Market Review by Type (2016-2021)
        4.1.1 Global Recombinant Hepatitis B Vaccine Sales Market Share by Type (2016-2021)
        4.1.2 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Type (2016-2021)
        4.1.3 Global Recombinant Hepatitis B Vaccine Price by Type (2016-2021)
    4.2 Global Recombinant Hepatitis B Vaccine Market Estimates and Forecasts by Type (2022-2027)
        4.2.1 Global Recombinant Hepatitis B Vaccine Sales Forecast by Type (2022-2027)
        4.2.2 Global Recombinant Hepatitis B Vaccine Revenue Forecast by Type (2022-2027)
        4.2.3 Global Recombinant Hepatitis B Vaccine Price Forecast by Type (2022-2027)
5 Global Recombinant Hepatitis B Vaccine Market Size by Application
    5.1 Global Recombinant Hepatitis B Vaccine Historic Market Review by Application (2016-2021)
        5.1.1 Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2016-2021)
        5.1.2 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Application (2016-2021)
        5.1.3 Global Recombinant Hepatitis B Vaccine Price by Application (2016-2021)
    5.2 Global Recombinant Hepatitis B Vaccine Market Estimates and Forecasts by Application (2022-2027)
        5.2.1 Global Recombinant Hepatitis B Vaccine Sales Forecast by Application (2022-2027)
        5.2.2 Global Recombinant Hepatitis B Vaccine Revenue Forecast by Application (2022-2027)
        5.2.3 Global Recombinant Hepatitis B Vaccine Price Forecast by Application (2022-2027)

6 North America Recombinant Hepatitis B Vaccine Market Facts & Figures
    6.1 North America Recombinant Hepatitis B Vaccine Sales by Company
        6.1.1 North America Recombinant Hepatitis B Vaccine Sales by Company (2016-2021)
        6.1.2 North America Recombinant Hepatitis B Vaccine Revenue by Company (2016-2021)
    6.2 North America Recombinant Hepatitis B Vaccine Sales Breakdown by Type
        6.2.1 North America Recombinant Hepatitis B Vaccine Sales Breakdown by Type (2016-2021)
        6.2.2 North America Recombinant Hepatitis B Vaccine Sales Breakdown by Type (2022-2027)
    6.3 North America Recombinant Hepatitis B Vaccine Sales Breakdown by Application
        6.3.1 North America Recombinant Hepatitis B Vaccine Sales Breakdown by Application (2016-2021)
        6.3.2 North America Recombinant Hepatitis B Vaccine Sales Breakdown by Application (2022-2027)

7 Europe Recombinant Hepatitis B Vaccine Market Facts & Figures
    7.1 Europe Recombinant Hepatitis B Vaccine Sales by Company
        7.1.1 Europe Recombinant Hepatitis B Vaccine Sales by Company (2016-2021)
        7.1.2 Europe Recombinant Hepatitis B Vaccine Revenue by Company (2016-2021)
    7.2 Europe Recombinant Hepatitis B Vaccine Sales Breakdown by Type
        7.2.1 Europe Recombinant Hepatitis B Vaccine Sales Breakdown by Type (2016-2021)
        7.2.2 Europe Recombinant Hepatitis B Vaccine Sales Breakdown by Type (2022-2027)
    7.3 Europe Recombinant Hepatitis B Vaccine Sales Breakdown by Application
        7.3.1 Europe 144 Sales Breakdown by Application (2016-2021)
        7.3.2 Europe 144 Sales Breakdown by Application (2022-2027)

8 China Recombinant Hepatitis B Vaccine Market Facts & Figures
    8.1 China Recombinant Hepatitis B Vaccine Sales by Company
        8.1.1 China Recombinant Hepatitis B Vaccine Sales by Company (2016-2021)
        8.1.2 China Recombinant Hepatitis B Vaccine Revenue by Company (2016-2021)
    8.2 China Recombinant Hepatitis B Vaccine Sales Breakdown by Type
        8.2.1 China Recombinant Hepatitis B Vaccine Sales Breakdown by Type (2016-2021)
        8.2.2 China Recombinant Hepatitis B Vaccine Sales Breakdown by Type (2022-2027)
    8.3 China Recombinant Hepatitis B Vaccine Sales Breakdown by Application
        8.3.1 China 316 Sales Breakdown by Application (2016-2021)
        8.3.2 China 316 Sales Breakdown by Application (2022-2027)

9 Japan Recombinant Hepatitis B Vaccine Market Facts & Figures
    9.1 Japan Recombinant Hepatitis B Vaccine Sales by Company
        9.1.1 Japan Recombinant Hepatitis B Vaccine Sales by Company (2016-2021)
        9.1.2 Japan Recombinant Hepatitis B Vaccine Revenue by Company (2016-2021)
    9.2 Japan Recombinant Hepatitis B Vaccine Sales Breakdown by Type
        9.2.1 Japan Recombinant Hepatitis B Vaccine Sales Breakdown by Type (2016-2021)
        9.2.2 Japan Recombinant Hepatitis B Vaccine Sales Breakdown by Type (2022-2027)
    9.3 Japan Recombinant Hepatitis B Vaccine Sales Breakdown by Application
        9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
        9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Recombinant Hepatitis B Vaccine Market Facts & Figures
    10.1 Southeast Asia Recombinant Hepatitis B Vaccine Sales by Company
        10.1.1 Southeast Asia Recombinant Hepatitis B Vaccine Sales by Company (2016-2021)
        10.1.2 Southeast Asia Recombinant Hepatitis B Vaccine Revenue by Company (2016-2021)
    10.2 Southeast Asia Recombinant Hepatitis B Vaccine Sales Breakdown by Type
        10.2.1 Southeast Asia Recombinant Hepatitis B Vaccine Sales Breakdown by Type (2016-2021)
        10.2.2 Southeast Asia Recombinant Hepatitis B Vaccine Sales Breakdown by Type (2022-2027)
    10.3 Southeast Asia Recombinant Hepatitis B Vaccine Sales Breakdown by Application
        10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
        10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Recombinant Hepatitis B Vaccine Market Facts & Figures
    11.1 India Recombinant Hepatitis B Vaccine Sales by Company
        11.1.1 India Recombinant Hepatitis B Vaccine Sales by Company (2016-2021)
        11.1.2 India Recombinant Hepatitis B Vaccine Revenue by Company (2016-2021)
    11.2 India Recombinant Hepatitis B Vaccine Sales Breakdown by Type
        11.2.1 India Recombinant Hepatitis B Vaccine Sales Breakdown by Type (2016-2021)
        11.2.2 India Recombinant Hepatitis B Vaccine Sales Breakdown by Type (2022-2027)
    11.3 India Recombinant Hepatitis B Vaccine Sales Breakdown by Application
        11.3.1 India Recombinant Hepatitis B Vaccine Sales Breakdown by Application (2016-2021)
        11.3.2 India Recombinant Hepatitis B Vaccine Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Recombinant Hepatitis B Vaccine Business
    12.1 Merck
        12.1.1 Merck Corporation Information
        12.1.2 Merck Business Overview
        12.1.3 Merck Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Merck Recombinant Hepatitis B Vaccine Products Offered
        12.1.5 Merck Recent Development
    12.2 GlaxoSmithKline Plc
        12.2.1 GlaxoSmithKline Plc Corporation Information
        12.2.2 GlaxoSmithKline Plc Business Overview
        12.2.3 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Products Offered
        12.2.5 GlaxoSmithKline Plc Recent Development
    12.3 Pfizer Inc.
        12.3.1 Pfizer Inc. Corporation Information
        12.3.2 Pfizer Inc. Business Overview
        12.3.3 Pfizer Inc. Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Pfizer Inc. Recombinant Hepatitis B Vaccine Products Offered
        12.3.5 Pfizer Inc. Recent Development
    12.4 Sanofi Pasteur
        12.4.1 Sanofi Pasteur Corporation Information
        12.4.2 Sanofi Pasteur Business Overview
        12.4.3 Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Sanofi Pasteur Recombinant Hepatitis B Vaccine Products Offered
        12.4.5 Sanofi Pasteur Recent Development
    12.5 CSL Limited
        12.5.1 CSL Limited Corporation Information
        12.5.2 CSL Limited Business Overview
        12.5.3 CSL Limited Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 CSL Limited Recombinant Hepatitis B Vaccine Products Offered
        12.5.5 CSL Limited Recent Development
    12.6 Emergent Biosolutions
        12.6.1 Emergent Biosolutions Corporation Information
        12.6.2 Emergent Biosolutions Business Overview
        12.6.3 Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Emergent Biosolutions Recombinant Hepatitis B Vaccine Products Offered
        12.6.5 Emergent Biosolutions Recent Development
    12.7 Serum Institute of India
        12.7.1 Serum Institute of India Corporation Information
        12.7.2 Serum Institute of India Business Overview
        12.7.3 Serum Institute of India Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Serum Institute of India Recombinant Hepatitis B Vaccine Products Offered
        12.7.5 Serum Institute of India Recent Development
    12.8 Johnson & Johnson
        12.8.1 Johnson & Johnson Corporation Information
        12.8.2 Johnson & Johnson Business Overview
        12.8.3 Johnson & Johnson Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Johnson & Johnson Recombinant Hepatitis B Vaccine Products Offered
        12.8.5 Johnson & Johnson Recent Development
    12.9 Hualan Biological Engineering
        12.9.1 Hualan Biological Engineering Corporation Information
        12.9.2 Hualan Biological Engineering Business Overview
        12.9.3 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Products Offered
        12.9.5 Hualan Biological Engineering Recent Development
    12.10 NCPC
        12.10.1 NCPC Corporation Information
        12.10.2 NCPC Business Overview
        12.10.3 NCPC Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 NCPC Recombinant Hepatitis B Vaccine Products Offered
        12.10.5 NCPC Recent Development
    12.11 China National Biotec Group
        12.11.1 China National Biotec Group Corporation Information
        12.11.2 China National Biotec Group Business Overview
        12.11.3 China National Biotec Group Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 China National Biotec Group Recombinant Hepatitis B Vaccine Products Offered
        12.11.5 China National Biotec Group Recent Development
    12.12 Dalian Hissen Bio-pharm
        12.12.1 Dalian Hissen Bio-pharm Corporation Information
        12.12.2 Dalian Hissen Bio-pharm Business Overview
        12.12.3 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.12.4 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Products Offered
        12.12.5 Dalian Hissen Bio-pharm Recent Development
    12.13 Beijing Tiantan Biological
        12.13.1 Beijing Tiantan Biological Corporation Information
        12.13.2 Beijing Tiantan Biological Business Overview
        12.13.3 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.13.4 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Products Offered
        12.13.5 Beijing Tiantan Biological Recent Development

13 Recombinant Hepatitis B Vaccine Manufacturing Cost Analysis
    13.1 Recombinant Hepatitis B Vaccine Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of Recombinant Hepatitis B Vaccine
    13.4 Recombinant Hepatitis B Vaccine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 Recombinant Hepatitis B Vaccine Distributors List
    14.3 Recombinant Hepatitis B Vaccine Customers

15 Market Dynamics
    15.1 Recombinant Hepatitis B Vaccine Market Trends
    15.2 Recombinant Hepatitis B Vaccine Drivers
    15.3 Recombinant Hepatitis B Vaccine Market Challenges
    15.4 Recombinant Hepatitis B Vaccine Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer
List of Tables
    Table 1. Global Recombinant Hepatitis B Vaccine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
    Table 2. Global Recombinant Hepatitis B Vaccine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
    Table 3. Global Recombinant Hepatitis B Vaccine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
    Table 4. Global Recombinant Hepatitis B Vaccine Sales (K Units) by Region (2016-2021)
    Table 5. Global Recombinant Hepatitis B Vaccine Sales Market Share by Region (2016-2021)
    Table 6. Global Recombinant Hepatitis B Vaccine Revenue (US$ Million) Market Share by Region (2016-2021))
    Table 7. Global Recombinant Hepatitis B Vaccine Revenue Share by Region (2016-2021)
    Table 8. Global Recombinant Hepatitis B Vaccine Sales (K Units) Forecast by Region (2022-2027)
    Table 9. Global Recombinant Hepatitis B Vaccine Sales Market Share Forecast by Region (2022-2027)
    Table 10. Global Recombinant Hepatitis B Vaccine Revenue (US$ Million) Forecast by Region (2022-2027)
    Table 11. Global Recombinant Hepatitis B Vaccine Revenue Share Forecast by Region (2022-2027)
    Table 12. Global Recombinant Hepatitis B Vaccine Sales (K Units) of Key Companies (2016-2021)
    Table 13. Global Recombinant Hepatitis B Vaccine Sales Share by Company (2016-2021)
    Table 14. Global Recombinant Hepatitis B Vaccine Revenue (US$ Million) by Company (2016-2021)
    Table 15. Global Recombinant Hepatitis B Vaccine Revenue Share by Company (2016-2021)
    Table 16. Global Recombinant Hepatitis B Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Hepatitis B Vaccine as of 2020)
    Table 17. Global Recombinant Hepatitis B Vaccine Average Price (US$/Unit) of Key Company (2016-2021)
    Table 18. Manufacturers Recombinant Hepatitis B Vaccine Manufacturing Sites and Area Served
    Table 19. Manufacturers Recombinant Hepatitis B Vaccine Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Recombinant Hepatitis B Vaccine Sales (K Units) by Type (2016-2021)
    Table 22. Global Recombinant Hepatitis B Vaccine Sales Share by Type (2016-2021)
    Table 23. Global Recombinant Hepatitis B Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 24. Global Recombinant Hepatitis B Vaccine Price (US$/Unit) by Type (2016-2021)
    Table 25. Global Recombinant Hepatitis B Vaccine Sales Share by Type (2022-2027)
    Table 26. Global Recombinant Hepatitis B Vaccine Revenue (US$ Million) Market Share by Type (2022-2027) 
    Table 27. Global Recombinant Hepatitis B Vaccine Revenue Share by Type (2022-2027)
    Table 28. Global Recombinant Hepatitis B Vaccine Price (US$/Unit) by Type (2022-2027)
    Table 29. Global Recombinant Hepatitis B Vaccine Sales (K Units) by Application (2016-2021) 
    Table 30. Global Recombinant Hepatitis B Vaccine Sales Share by Application (2016-2021)
    Table 31. Global Recombinant Hepatitis B Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 32. Global Recombinant Hepatitis B Vaccine Price (US$/Unit) by Application (2016-2021)
    Table 33. Global Recombinant Hepatitis B Vaccine Sales (K Units) by Application (2022-2027)
    Table 34. Global Recombinant Hepatitis B Vaccine Sales Share by Application (2022-2027)
    Table 35. Global Recombinant Hepatitis B Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 36. Global Recombinant Hepatitis B Vaccine Revenue Share by Application (2022-2027)
    Table 37. Global Recombinant Hepatitis B Vaccine Price (US$/Unit) by Application (2022-2027)
    Table 38. North America Recombinant Hepatitis B Vaccine Sales (K Units) by Company (2016-2021)
    Table 39. North America Recombinant Hepatitis B Vaccine Sales Market Share by Company (2016-2021)
    Table 40. North America Recombinant Hepatitis B Vaccine Revenue by Company (2016-2021) & (US$ Million)
    Table 41. North America Recombinant Hepatitis B Vaccine Revenue Market Share by Company (2016-2021)
    Table 42. North America Recombinant Hepatitis B Vaccine Sales by Type (2016-2021) & (K Units)
    Table 43. North America Recombinant Hepatitis B Vaccine Sales Market Share by Type (2016-2021)
    Table 44. North America Recombinant Hepatitis B Vaccine Sales by Type (2022-2027) & (K Units)
    Table 45. North America Recombinant Hepatitis B Vaccine Sales Market Share by Type (2022-2027)
    Table 46. North America Recombinant Hepatitis B Vaccine Sales by Application (2016-2021) & (K Units)
    Table 47. North America Recombinant Hepatitis B Vaccine Sales Market Share by Application (2016-2021)
    Table 48. North America Recombinant Hepatitis B Vaccine Sales by Application (2022-2027) & (K Units)
    Table 49. North America Recombinant Hepatitis B Vaccine Sales Market Share by Application (2022-2027)
    Table 50. Europe Recombinant Hepatitis B Vaccine Sales (K Units) by Company (2016-2021)
    Table 51. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Company (2016-2021)
    Table 52. Europe Recombinant Hepatitis B Vaccine Revenue by Company (2016-2021) & (US$ Million)
    Table 53. Europe Recombinant Hepatitis B Vaccine Revenue Market Share by Company (2016-2021)
    Table 54. Europe Recombinant Hepatitis B Vaccine Sales by Type (2016-2021) & (K Units)
    Table 55. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Type (2016-2021)
    Table 56. Europe Recombinant Hepatitis B Vaccine Sales by Type (2022-2027) & (K Units)
    Table 57. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Type (2022-2027)
    Table 58. Europe Recombinant Hepatitis B Vaccine Sales by Application (2016-2021) & (K Units)
    Table 59. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Application (2016-2021)
    Table 60. Europe Recombinant Hepatitis B Vaccine Sales by Application (2022-2027) & (K Units)
    Table 61. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Application (2022-2027)
    Table 62. China Recombinant Hepatitis B Vaccine Sales (K Units) by Company (2016-2021)
    Table 63. China Recombinant Hepatitis B Vaccine Sales Market Share by Company (2016-2021)
    Table 64. China Recombinant Hepatitis B Vaccine Revenue by Company (2016-2021) & (US$ Million)
    Table 65. China Recombinant Hepatitis B Vaccine Revenue Market Share by Company (2016-2021)
    Table 66. China Recombinant Hepatitis B Vaccine Sales by Type (2016-2021) & (K Units)
    Table 67. China Recombinant Hepatitis B Vaccine Sales Market Share by Type (2016-2021)
    Table 68. China Recombinant Hepatitis B Vaccine Sales by Type (2022-2027) & (K Units)
    Table 69. China Recombinant Hepatitis B Vaccine Sales Market Share by Type (2022-2027)
    Table 70. China Recombinant Hepatitis B Vaccine Sales by Application (2016-2021) & (K Units)
    Table 71. China Recombinant Hepatitis B Vaccine Sales Market Share by Application (2016-2021)
    Table 72. China Recombinant Hepatitis B Vaccine Sales by Application (2022-2027) & (K Units)
    Table 73. China Recombinant Hepatitis B Vaccine Sales Market Share by Application (2022-2027)
    Table 74. Japan Recombinant Hepatitis B Vaccine Sales (K Units) by Company (2016-2021)
    Table 75. Japan Recombinant Hepatitis B Vaccine Sales Market Share by Company (2016-2021)
    Table 76. Japan Recombinant Hepatitis B Vaccine Revenue by Company (2016-2021) & (US$ Million)
    Table 77. Japan Recombinant Hepatitis B Vaccine Revenue Market Share by Company (2016-2021)
    Table 78. Japan Recombinant Hepatitis B Vaccine Sales by Type (2016-2021) & (K Units)
    Table 79. Japan Recombinant Hepatitis B Vaccine Sales Market Share by Type (2016-2021)
    Table 80. Japan Recombinant Hepatitis B Vaccine Sales by Type (2022-2027) & (K Units)
    Table 81. Japan Recombinant Hepatitis B Vaccine Sales Market Share by Type (2022-2027)
    Table 82. Japan Recombinant Hepatitis B Vaccine Sales by Application (2016-2021) & (K Units)
    Table 83. Japan Recombinant Hepatitis B Vaccine Sales Market Share by Application (2016-2021)
    Table 84. Japan Recombinant Hepatitis B Vaccine Sales by Application (2022-2027) & (K Units)
    Table 85. Japan Recombinant Hepatitis B Vaccine Sales Market Share by Application (2022-2027)
    Table 86. Southeast Asia Recombinant Hepatitis B Vaccine Sales (K Units) by Company (2016-2021)
    Table 87. Southeast Asia Recombinant Hepatitis B Vaccine Sales Market Share by Company (2016-2021)
    Table 88. Southeast Asia Recombinant Hepatitis B Vaccine Revenue by Company (2016-2021) & (US$ Million)
    Table 89. Southeast Asia Recombinant Hepatitis B Vaccine Revenue Market Share by Company (2016-2021)
    Table 90. Southeast Asia Recombinant Hepatitis B Vaccine Sales by Type (2016-2021) & (K Units)
    Table 91. Southeast Asia Recombinant Hepatitis B Vaccine Sales Market Share by Type (2016-2021)
    Table 92. Southeast Asia Recombinant Hepatitis B Vaccine Sales by Type (2022-2027) & (K Units)
    Table 93. Southeast Asia Recombinant Hepatitis B Vaccine Sales Market Share by Type (2022-2027)
    Table 94. Southeast Asia Recombinant Hepatitis B Vaccine Sales by Application (2016-2021) & (K Units)
    Table 95. Southeast Asia Recombinant Hepatitis B Vaccine Sales Market Share by Application (2016-2021)
    Table 96. Southeast Asia Recombinant Hepatitis B Vaccine Sales by Application (2022-2027) & (K Units)
    Table 97. Southeast Asia Recombinant Hepatitis B Vaccine Sales Market Share by Application (2022-2027)
    Table 98. India Recombinant Hepatitis B Vaccine Sales (K Units) by Company (2016-2021)
    Table 99. India Recombinant Hepatitis B Vaccine Sales Market Share by Company (2016-2021)
    Table 100. India Recombinant Hepatitis B Vaccine Revenue by Company (2016-2021) & (US$ Million)
    Table 101. India Recombinant Hepatitis B Vaccine Revenue Market Share by Company (2016-2021)
    Table 102. India Recombinant Hepatitis B Vaccine Sales by Type (2016-2021) & (K Units)
    Table 103. India Recombinant Hepatitis B Vaccine Sales Market Share by Type (2016-2021)
    Table 104. India Recombinant Hepatitis B Vaccine Sales by Type (2022-2027) & (K Units)
    Table 105. India Recombinant Hepatitis B Vaccine Sales Market Share by Type (2022-2027)
    Table 106. India Recombinant Hepatitis B Vaccine Sales by Application (2016-2021) & (K Units)
    Table 107. India Recombinant Hepatitis B Vaccine Sales Market Share by Application (2016-2021)
    Table 108. India Recombinant Hepatitis B Vaccine Sales by Application (2022-2027) & (K Units)
    Table 109. India Recombinant Hepatitis B Vaccine Sales Market Share by Application (2022-2027)
    Table 110. Merck Corporation Information
    Table 111. Merck Description and Business Overview
    Table 112. Merck Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 113. Merck Recombinant Hepatitis B Vaccine Product
    Table 114. Merck Recent Development
    Table 115. GlaxoSmithKline Plc Corporation Information
    Table 116. GlaxoSmithKline Plc Description and Business Overview
    Table 117. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 118. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product
    Table 119. GlaxoSmithKline Plc Recent Development
    Table 120. Pfizer Inc. Corporation Information
    Table 121. Pfizer Inc. Description and Business Overview
    Table 122. Pfizer Inc. Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 123. Pfizer Inc. Recombinant Hepatitis B Vaccine Product
    Table 124. Pfizer Inc. Recent Development
    Table 125. Sanofi Pasteur Corporation Information
    Table 126. Sanofi Pasteur Description and Business Overview
    Table 127. Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 128. Sanofi Pasteur Recombinant Hepatitis B Vaccine Product
    Table 129. Sanofi Pasteur Recent Development
    Table 130. CSL Limited Corporation Information
    Table 131. CSL Limited Description and Business Overview
    Table 132. CSL Limited Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 133. CSL Limited Recombinant Hepatitis B Vaccine Product
    Table 134. CSL Limited Recent Development
    Table 135. Emergent Biosolutions Corporation Information
    Table 136. Emergent Biosolutions Description and Business Overview
    Table 137. Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 138. Emergent Biosolutions Recombinant Hepatitis B Vaccine Product
    Table 139. Emergent Biosolutions Recent Development
    Table 140. Serum Institute of India Corporation Information
    Table 141. Serum Institute of India Description and Business Overview
    Table 142. Serum Institute of India Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 143. Serum Institute of India Recombinant Hepatitis B Vaccine Product
    Table 144. Serum Institute of India Recent Development
    Table 145. Johnson & Johnson Corporation Information
    Table 146. Johnson & Johnson Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 147. Johnson & Johnson Description and Business Overview
    Table 148. Johnson & Johnson Recombinant Hepatitis B Vaccine Product
    Table 149. Johnson & Johnson Recent Development
    Table 150. Hualan Biological Engineering Corporation Information
    Table 151. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 152. Hualan Biological Engineering Description and Business Overview
    Table 153. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product
    Table 154. Hualan Biological Engineering Recent Development
    Table 155. NCPC Corporation Information
    Table 156. NCPC Description and Business Overview
    Table 157. NCPC Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 158. NCPC Recombinant Hepatitis B Vaccine Product
    Table 159. NCPC Recent Development
    Table 160. China National Biotec Group Corporation Information
    Table 161. China National Biotec Group Description and Business Overview
    Table 162. China National Biotec Group Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 163. China National Biotec Group Recombinant Hepatitis B Vaccine Product
    Table 164. China National Biotec Group Recent Development
    Table 165. Dalian Hissen Bio-pharm Corporation Information
    Table 166. Dalian Hissen Bio-pharm Description and Business Overview
    Table 167. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 168. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product
    Table 169. Dalian Hissen Bio-pharm Recent Development
    Table 170. Beijing Tiantan Biological Corporation Information
    Table 171. Beijing Tiantan Biological Description and Business Overview
    Table 172. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 173. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product
    Table 174. Beijing Tiantan Biological Recent Development
    Table 175. Production Base and Market Concentration Rate of Raw Material
    Table 176. Key Suppliers of Raw Materials
    Table 177. Recombinant Hepatitis B Vaccine Distributors List
    Table 178. Recombinant Hepatitis B Vaccine Customers List
    Table 179. Recombinant Hepatitis B Vaccine Market Trends
    Table 180. Recombinant Hepatitis B Vaccine Market Drivers
    Table 181. Recombinant Hepatitis B Vaccine Market Challenges
    Table 182. Recombinant Hepatitis B Vaccine Market Restraints
    Table 183. Research Programs/Design for This Report
    Table 184. Key Data Information from Secondary Sources
    Table 185. Key Data Information from Primary Sources
List of Figures
    Figure 1. Recombinant Hepatitis B Vaccine Product Picture
    Figure 2. Global Recombinant Hepatitis B Vaccine Sales Market Share by Type in 2021 & 2027
    Figure 3. Type I Product Picture
    Figure 4. Type II Product Picture
    Figure 5. Global Recombinant Hepatitis B Vaccine Sales Market Share by Application in 2021 & 2027
    Figure 6. Newborn Examples
    Figure 7. Primary School Students Examples
    Figure 8. Adult Examples
    Figure 9. Global Recombinant Hepatitis B Vaccine Sales, (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Recombinant Hepatitis B Vaccine Sales Growth Rate (2016-2027) & (US$ Million)
    Figure 11. Global Recombinant Hepatitis B Vaccine Sales (K Units) Growth Rate (2016-2027)
    Figure 12. Global Recombinant Hepatitis B Vaccine Price Trends Growth Rate (2016-2027) (US$/Unit)
    Figure 13. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Region: 2016 VS 2021
    Figure 14. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Region: 2021 VS 2027
    Figure 15. North America Recombinant Hepatitis B Vaccine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 16. North America Recombinant Hepatitis B Vaccine Sales (K Units) Growth Rate (2016-2027)
    Figure 17. Europe Recombinant Hepatitis B Vaccine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 18. Europe Recombinant Hepatitis B Vaccine Sales (Million USD) Growth Rate (2016-2027)
    Figure 19. China Recombinant Hepatitis B Vaccine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 20. China Recombinant Hepatitis B Vaccine Sales (Million USD) and Growth Rate (2016-2027)
    Figure 21. Japan Recombinant Hepatitis B Vaccine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 22. Japan Recombinant Hepatitis B Vaccine Sales (Million USD) Growth Rate (2016-2027)
    Figure 23. Southeast Asia Recombinant Hepatitis B Vaccine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 24. Southeast Asia Recombinant Hepatitis B Vaccine Sales (Million USD) Growth Rate (2016-2027)
    Figure 25. India Recombinant Hepatitis B Vaccine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 26. India Recombinant Hepatitis B Vaccine Sales (Million USD) Growth Rate (2016-2027)
    Figure 27. Global 5 Largest Recombinant Hepatitis B Vaccine Players Market Share by Revenue in Recombinant Hepatitis B Vaccine: 2016 & 2020
    Figure 28. Recombinant Hepatitis B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 29. Global Recombinant Hepatitis B Vaccine Revenue Share by Type (2016-2021)
    Figure 30. Global Recombinant Hepatitis B Vaccine Revenue Growth Rate by Type in 2016 & 2020
    Figure 31. Global Recombinant Hepatitis B Vaccine Revenue Share by Application (2016-2021)
    Figure 32. Global Recombinant Hepatitis B Vaccine Revenue Growth Rate by Application in 2016 & 2020
    Figure 33. North America Recombinant Hepatitis B Vaccine Sales Market Share by Type in 2020
    Figure 34. North America Recombinant Hepatitis B Vaccine Sales Market Share by Application in 2020
    Figure 35. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Type in 2020
    Figure 36. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Application in 2020
    Figure 37. China Recombinant Hepatitis B Vaccine Sales Market Share by Type in 2020
    Figure 38. China Recombinant Hepatitis B Vaccine Sales Market Share by Application in 2020
    Figure 39. Japan Recombinant Hepatitis B Vaccine Sales Market Share by Type in 2020
    Figure 40. Japan Recombinant Hepatitis B Vaccine Sales Market Share by Application in 2020
    Figure 41. Southeast Asia Recombinant Hepatitis B Vaccine Sales Market Share by Type in 2020
    Figure 42. Southeast Asia Recombinant Hepatitis B Vaccine Sales Market Share by Application in 2020
    Figure 43. India Recombinant Hepatitis B Vaccine Sales Market Share by Type in 2020
    Figure 44. India Recombinant Hepatitis B Vaccine Sales Market Share by Application in 2020
    Figure 45. Key Raw Materials Price Trend
    Figure 46. Manufacturing Cost Structure of Recombinant Hepatitis B Vaccine 
    Figure 47. Manufacturing Process Analysis of Recombinant Hepatitis B Vaccine
    Figure 48. Recombinant Hepatitis B Vaccine Industrial Chain Analysis
    Figure 49. Channels of Distribution
    Figure 50. Distributors Profiles
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation 
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
GlaxoSmithKline Plc
Pfizer Inc.
Sanofi Pasteur
CSL Limited
Emergent Biosolutions
Serum Institute of India
Johnson & Johnson
Hualan Biological Engineering
NCPC
China National Biotec Group
Dalian Hissen Bio-pharm
Beijing Tiantan Biological
Frequently Asked Questions
Recombinant Hepatitis B Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Recombinant Hepatitis B Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Recombinant Hepatitis B Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Wisdom Screen

The global Wisdom Screen market is segmented by company, region (country), by Type, and by Applic ... Read More